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Introduction
Surface-expressed immunoglobulins (Ig) are the hallmark of B cells. During precursor development in bone marrow, each developing B cell creates an Ig molecule with unique specificity through genomic reassembly of genetic elements in their Ig loci (1) . This results in the expression of a receptor with the IgM isotype, which is crucial for naive B-cell survival and activation of the cell to respond to a specific antigen (2, 3) . In addition to IgM, circulating naive B cells co-express a receptor with the IgD isotype, resulting from alternative splicing of the exons encoding the variable domain to Cδ constant regions encoding exons (4) (5) (6) . IgM function has been extensively studied, and even though IgD co-expression is highly conserved in jawed vertebrates (7) , the biological role of surface IgD remains enigmatic even 50 years after its initial discovery (8, 9) . (10, 11) , prior to the identification of co-expression with IgM on the surface of B cells (12) (13) (14) (15) . The IgM isotype is already expressed in progenitor B cells, either with the surrogate light chains as pre-B-cell receptor (pre-BCR) on pre-BII cells, or together with a rearranged Ig light chain on immature B cells as BCR. IgM is first expressed as pre-BCR (μ chain with surrogate light chains) by pre-B cells. IgD expression is first up-regulated after migration to the periphery at the transitional B-cell stage, and splicing to IgD is critically dependent on Zinc-finger protein ZFP318 (16, 17) . In mature naive B cells, the levels of IgD exceed that of IgM, and are downregulated after antigen recognition (18, 19) . and are capable of generating responses to T-cell dependent and -independent antigens (23) (24) (25) . Still, affinity maturation is slightly delayed in the primary immune response, and the signal transduction differs qualitatively between IgM and IgD (26) . Together, these studies indicate potential roles for surface IgD in B-cell homeostasis and immune responses, but its function on B cells in vivo immunity remains unclear and prompted us to investigate this in vivo.
IgD was first described in 1965 by Rowe et al. as serum Ig
We here studied the in vivo function of surface IgD on human B cells in four individuals from one family who carried heterozygous germline nonsense mutations in the IGHD gene.
Detailed clinical, molecular and cellular analyses of the family was performed, and included direct comparison of the B cells expressing the wildtype IGHD allele and those utilizing the IGHD mutant allele.
Results

Identification of a family with heterozygous nonsense mutations in IGHD
As part of the diagnostic work up, blood B cells were studied by flow cytometric immunophenotyping in a patient with nodular lymphocyte-predominant Hodgkin lymphoma (index; IGHD6). Peripheral blood B cells appeared polyclonal with a normal Igκ/Igλ ratio. (Fig. 1BC) . This heterozygous c.368G>A mutation results in mutation of a tryptophan (TGG) to a stop codon (TAG). Because the nonsense mutation (p.W123X) is already in exon 1, this allele will not give rise to a functional IgD molecule (Fig. 1D) , resulting in the lack of IgD membrane expression in ~50% of naive B cells in all affected individuals. The c.368G>A mutation was not present in the unaffected father and grandmother, nor in healthy control, and has not been reported in Ensembl (current as of December 2017).
Humoral immunity in IGHD heterozygous individuals
Extensive clinical and immunological work-up was performed on all 6 included family members. Except for the index case (Hodgkin lymphoma), only the affected aunt had a history of celiac disease and Turner syndrome). Besides reduced serum IgD, heterozygous IGHD-deficient individuals carried mostly normal serum Ig levels ( Table 1) . Specific antibody levels against previous vaccinations were normal in the two IGHD patients that were tested ( Table 2) . Reactivity analysis to a large panel of 13 autoantigens revealed the presence that nearly all contained somatic mutations. The mutation levels in IgA transcripts were slightly higher, and in IgG transcripts similar to unaffected controls (Fig. 3) . All IgA and IgG subclasses were present in carriers of the IGHD mutation with slightly but significantly reduced fractions of IgA2 and IgG1 in the carriers.
In conclusion, humoral immunity appears to be normal in carriers of the IGHD mutation with no overt signs of autoimmunity or immunodeficiency.
Molecular and immunophenotypic characteristics of IgD -naive B cells
In normal human B-cell development, IgD expression starts from the transition of immature to mature B cells, and coincides with the migration from bone marrow to the periphery (27, 28 (Fig. 3A) , whereas in the IGHD carriers this was 48.4% (Fig. 3A) . (Fig. 3B) . Consequently, IgM surface expression was similar between both subsets (Fig. 3C) . Importantly, surface CD79b expression levels were reduced in IgD -B cells. Thus, the IGHD nonsense mutation does not seem to affect IgM transcript and protein levels. However, mutant IGHD transcript levels were reduced, and the lack of IgD surface expression resulted in a decrease in the total amount of B-cell receptors on the surface of naive mature B cells. (Table S4) . Subsequently, we designated the IgA and IgG transcripts that used these 11 alleles into those derived from IGHD wild type and IGHD mutant alleles. IgA transcripts from IGHD wild type alleles and IgG transcripts from IGHD mutant alleles carried higher SHM frequencies than those of controls (Fig. 4B) .
Finally, we studied plasma cell differentiation from naive B cells in the presence or absence of IgD. Naive mature B cells from IGHD heterozygous individuals were sort-purified and stimulated in vitro with anti-IgM and anti-CD40 agonist or CpG to mimic T-cell dependent and T-cell independent secondary stimulation. After 6 days of culture, IgD + and IgD -B cells expressed similar levels of activation-induced cytidine deaminase (AID), as well as transcription factors IRF4 and XBP1 (Fig. 4C ).
In conclusion, the IgD + and IgD -naive B cell in heterozygous IGHD-deficient individuals show equal homeostasis and are similarly capable of differentiation into memory and plasma cells.
Discussion
In this study, we described four members from one family with heterozygous nonsense mutations in IGHD. Therefore, in all our study subjects, deficits of IgD-deficient B cells to specific antigens could have been obscured by IgD-expressing B cells.
In conclusion, in the absence of surface IgD, human B cells are normally produced and capable of antigen-dependent maturation that is not outcompeted by IgD+ B cells as assessed in our assays. Rather than affecting the "wiring" of B-cell differentiation and maturation, surface IgD might have a more specific role in modulating responses to antigen based on their structural organization.
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Materials and Methods
Patients
This family came to our attention when the index (IGHD6; Table 1 
Flow cytometric immunophenotyping and purification of B-cells from human blood
All peripheral blood samples were obtained with informed consent and according to the Table S1 ). After preparation, cells were measured on a 4-laser LSRFortessa flow cytometer (BD Biosciences) using standardized settings (30) . Data were analyzed with FACSDiva software V8.0 (BD Biosciences).
DNA isolation and IGHD mutation analysis
DNA was isolated from post-Ficoll granulocytes and sorted B-cell subsets with the GenElute mammalian genomic DNA miniprep kit (Sigma-Aldrich). All 8 IGHD encoding exons including splice sites (NCBI NG_001019) were PCR amplified (Table S2) 
Replication history analysis using the KREC assay
The replication history of sorted IgD+ and IgD-transitional (CD19 
In vitro plasma cell differentiation of purified naive B cells
IgD + and IgD -naive B cells were purified and cultured with combinations of anti-IgM F(ab')2, anti-CD40 agonist, CpG ODN2006, and IL-21, as described previously (36, 37) .
Cells were harvested after a 6-day culture for TaqMan-based quantitative RT-PCR on a
StepOnePlus (Applied Biosystems). Target gene expression levels were determined in freshly isolated and cultured cells with intron-spanning primes and fluorogenic probes (Table E3) and expressed relative to the ABL control gene (38) . All quantitative RT-PCR reactions were performed in duplicate.
Serology
Using a nephelometric method, the levels were determined of CRP, IgG, IgA, IgM and IgG 
Statistical analyses
Statistical analyses were performed with the Mann-Whitney U test, paired student's T-test, or χ 2 test as indicated in detail in Figure legends . p values <0.05 were considered statistically significant. Table S1 . Antibodies used for flow cytometry Table S2 . Primer sequences for PCR amplification and sequencing of IGHD coding regions and splice sites from genomic DNA Table S3 . Primers and probes used for quantification of gene transcripts Table S4 . Polymorphic IGHV alleles in IGHD carriers 
Supplementary Material
